Biology:Nucleoside

From HandWiki
Revision as of 22:56, 13 February 2024 by QCDvac (talk | contribs) (over-write)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Any of several glycosylamines comprising a nucleobase and a sugar molecule
deoxyadenosine
deoxyadenosine
adenosine
adenosine
Two corresponding nucleosides, the deoxyribonucleoside, deoxyadenosine, and the ribonucleoside, adenosine. The line-angle molecular representation implies carbon atoms at each angle, each with enough hydrogen atoms to fill its four-bond valency.

Nucleosides are glycosylamines that can be thought of as nucleotides without a phosphate group. A nucleoside consists simply of a nucleobase (also termed a nitrogenous base) and a five-carbon sugar (ribose or 2'-deoxyribose) whereas a nucleotide is composed of a nucleobase, a five-carbon sugar, and one or more phosphate groups. In a nucleoside, the anomeric carbon is linked through a glycosidic bond to the N9 of a purine or the N1 of a pyrimidine. Nucleotides are the molecular building blocks of DNA and RNA.

List of nucleosides and corresponding nucleobases

This list does not include modified nucleobases and the corresponding nucleosides

The reason for 2 symbols, shorter and longer, is that the shorter ones are better for contexts where explicit disambiguation is superfluous (because context disambiguates) and the longer ones are for contexts where explicit disambiguation is judged to be needed or wise. For example, when discussing long nucleobase sequences in genomes, the CATG symbol system is much preferable to the Cyt-Ade-Thy-Gua symbol system (see Nucleic acid sequence § Notation for examples), but in discussions where confusion is likelier, the unambiguous symbols can be used.

Nitrogenous base Ribonucleoside Deoxyribonucleoside
Chemical structure of adenine
adenine
symbol A or Ade
Chemical structure of adenosine
adenosine
symbol A or Ado
Chemical structure of deoxyadenosine
deoxyadenosine
symbol dA or dAdo
Chemical structure of guanine
guanine
symbol G or Gua
Chemical structure of guanosine
guanosine
symbol G or Guo
Chemical structure of deoxyguanosine
deoxyguanosine
symbol dG or dGuo
Chemical structure of thymine
thymine
(5-methyluracil)
symbol T or Thy
Chemical structure of 5-methyluridine
5-methyluridine
(ribothymidine)
symbol m⁵U
Chemical structure of thymidine
thymidine
(deoxythymidine)
symbol dT or dThd
(dated: T or Thd)
Chemical structure of uracil
uracil
symbol U or Ura
Chemical structure of uridine
uridine
symbol U or Urd
Chemical structure of deoxyuridine
deoxyuridine
symbol dU or dUrd
Chemical structure of cytosine
cytosine
symbol C or Cyt
Chemical structure of cytidine
cytidine
symbol C or Cyd
Chemical structure of deoxycytidine
deoxycytidine
symbol dC or dCyd

Sources

Nucleosides can be produced from nucleotides de novo, particularly in the liver, but they are more abundantly supplied via ingestion and digestion of nucleic acids in the diet, whereby nucleotidases break down nucleotides (such as the thymidine monophosphate) into nucleosides (such as thymidine) and phosphate. The nucleosides, in turn, are subsequently broken down in the lumen of the digestive system by nucleosidases into nucleobases and ribose or deoxyribose. In addition, nucleotides can be broken down inside the cell into nitrogenous bases, and ribose-1-phosphate or deoxyribose-1-phosphate.

Use in medicine and technology

In medicine several nucleoside analogues are used as antiviral or anticancer agents.[1][2][3][4] The viral polymerase incorporates these compounds with non-canonical bases. These compounds are activated in the cells by being converted into nucleotides. They are administered as nucleosides since charged nucleotides cannot easily cross cell membranes.

In molecular biology, several analogues of the sugar backbone exist. Due to the low stability of RNA, which is prone to hydrolysis, several more stable alternative nucleoside/nucleotide analogues that correctly bind to RNA are used. This is achieved by using a different backbone sugar. These analogues include locked nucleic acids (LNA), morpholinos and peptide nucleic acids (PNA).

In sequencing, dideoxynucleotides are used. These nucleotides possess the non-canonical sugar dideoxyribose, which lacks 3' hydroxyl group (which accepts the phosphate). DNA polymerases cannot distinguish between these and regular deoxyribonucleotides, but when incorporated a dideoxynucleotide cannot bond with the next base and the chain is terminated.

Prebiotic synthesis of ribonucleosides

In order to understand how life arose, knowledge is required of the chemical pathways that permit formation of the key building blocks of life under plausible prebiotic conditions. According to the RNA world hypothesis free-floating ribonucleosides and ribonucleotides were present in the primitive soup. Molecules as complex as RNA must have arisen from small molecules whose reactivity was governed by physico-chemical processes. RNA is composed of purine and pyrimidine nucleotides, both of which are necessary for reliable information transfer, and thus Darwinian natural selection and evolution. Nam et al.[5] demonstrated the direct condensation of nucleobases with ribose to give ribonucleosides in aqueous microdroplets, a key step leading to RNA formation. Also, a plausible prebiotic process for synthesizing pyrimidine and purine ribonucleosides and ribonucleotides using wet-dry cycles was presented by Becker et al.[6]

See also

References

  1. Ramesh, Deepthi; Vijayakumar, Balaji Gowrivel; Kannan, Tharanikkarasu (December 2020). "Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders". European Journal of Medicinal Chemistry 207: 112801. doi:10.1016/j.ejmech.2020.112801. PMID 32927231. 
  2. Galmarini, Carlos M.; MacKey, John R.; Dumontet, Charles (2002). "Nucleoside analogues and nucleobases in cancer treatment". The Lancet Oncology 3 (7): 415–424. doi:10.1016/S1470-2045(02)00788-X. PMID 12142171. 
  3. Jordheim, Lars Petter; Durantel, David; Zoulim, Fabien; Dumontet, Charles (2013). "Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases". Nature Reviews Drug Discovery 12 (6): 447–464. doi:10.1038/nrd4010. PMID 23722347. 
  4. Ramesh, Deepthi; Vijayakumar, Balaji Gowrivel; Kannan, Tharanikkarasu (12 February 2021). "Advances in Nucleoside and Nucleotide Analogues in Tackling Human Immunodeficiency Virus and Hepatitis Virus Infections". ChemMedChem 16 (9): 1403–1419. doi:10.1002/cmdc.202000849. PMID 33427377. https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202000849. Retrieved 13 March 2021. 
  5. Nam, Inho; Nam, Hong Gil; Zare, Richard N. (2018-01-02). "Abiotic synthesis of purine and pyrimidine ribonucleosides in aqueous microdroplets". Proceedings of the National Academy of Sciences of the United States of America 115 (1): 36–40. doi:10.1073/pnas.1718559115. PMID 29255025. Bibcode2018PNAS..115...36N. 
  6. Becker, Sidney; Feldmann, Jonas; Wiedemann, Stefan; Okamura, Hidenori; Schneider, Christina; Iwan, Katharina; Crisp, Antony; Rossa, Martin et al. (2019-10-04). "Unified prebiotically plausible synthesis of pyrimidine and purine RNA ribonucleotides". Science 366 (6461): 76–82. doi:10.1126/science.aax2747. PMID 31604305. Bibcode2019Sci...366...76B. https://epub.ub.uni-muenchen.de/71503/1/Science_Becker_2019.pdf. 

External links